Calciphylaxis clinical trials
The registry lists 23 studies for Calciphylaxis across more than 10 countries. 10 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-09-14.
Status
- Completed
- 8
- Recruiting
- 7
- Terminated
- 3
- Not yet recruiting
- 3
- Status unknown
- 2
Phase
- Phase 3
- 4
- Phase 1
- 3
- Phase 2
- 2
- Phase 4
- 1
- Early Phase 1
- 1
Where
- United States
- 12
- United Kingdom
- 4
- France
- 4
- Germany
- 2
- New Zealand
- 1
- Canada
- 1
Who runs them
Sanifit Therapeutics S. A. (2) · Massachusetts General Hospital (2) · Hope Pharmaceuticals (2) · The First Affiliated Hospital with Nanjing Medical University (1) · Sagar U. Nigwekar, MD, MMSc (1) · Jay C. Buckey Jr. (1) · Boston Medical Center (1) · Inozyme Pharma (1)
Studies
Recruiting first, then most recently updated. Showing 23 of 23 — search for more.
- Study of EPN-701 for the Treatment of CalciphylaxisNot yet recruitingNCT07583745Phase 21 country
- Partners Calciphylaxis BiobankRecruitingNCT030328351 country
- Emerging Indications for Hyperbaric Oxygen TreatmentNot yet recruitingNCT07240649Phase 4
- Anti-Interleukin-6 (IL6) in CalciphylaxisNot yet recruitingNCT07708038Phase 11 country
- Calciphylaxis in Patients With Chronic Kidney Disease - A Study of the Danish Calciphylaxis Research Initiative (DanCaRI)RecruitingNCT075112831 country
- Human Amniotic-Derived Mesenchymal Stem Cell Therapy for CalciphylaxisRecruitingNCT04592640Early Phase 11 country
- Rheopheresis as Adjuvant Treatment of CalciphylaxisRecruitingNCT04654000Not applicable1 country
- Better Evidence and Translation for CalciphylaxisRecruitingNCT05018221Phase 32 countries
- A Real-World Registry of Chronic Wounds and UlcersRecruitingNCT022807331 country
- National Registry of Rare Kidney DiseasesRecruitingNCT060658521 country
- SEAPORT 1: Study of INZ-701 in Adults With Hemodialysis-Dependent End-Stage Kidney DiseaseCompletedNCT06283589Phase 11 country
- Calciphylaxis : Population, Risk Factors, Diagnostic Practice, Therapeutic and OutcomeCompletedNCT028540461 country
- Phase 3 Study of SNF472 for CalciphylaxisCompletedNCT04195906Phase 36 countries
- Retrospective Study Evaluating the Contribution of Rheopheresis in the Treatment of Uremic Calciphylaxis (RHEO-CUA)CompletedNCT056331211 country
- Pathophysiology of Martorell Hypertensive Ischemic Leg Ulcer (HYTILU)CompletedNCT015783821 country
- A Phase 3 Clinical Trial of Intravenous Sodium Thiosulfate in Acute Calciphylaxis PatientsTerminatedNCT03150420Phase 33 countries
- Evaluation of Vitamin K Supplementation for Calcific Uremic ArteriolopathyCompletedNCT02278692Not applicable1 country
- Phase 2 Study With SNF472 in Calciphylaxis PatientsCompletedNCT02790073Phase 22 countries
- Observational Follow-up to ST-001 Calciphylaxis Pain Treatment With Intravenous Sodium ThiosulfateTerminatedNCT033199141 country
- The Early Administration of Sodium Thiosulfate Should Help to Reduce the Mortality of Dialysis Patients With Calciphylaxis, From a National CohortStatus unknownNCT031467931 country
- Randomized Double Blind Placebo Controlled Trial of Sodium Thiosulfate for the Treatment of Pain Associated With Calcific Uremic ArteriolopathTerminatedNCT02527213Phase 31 country
- European Calciphylaxis Registry NetworkStatus unknownNCT026353731 country
- Efficacy of Lanthanum Carbonate in CalciphylaxisCompletedNCT01289626Phase 11 country